LAUREN TURNER: Open Payments
NPI 1720442239 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $405 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $20 |
| EVOKE PHARMA, INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: General - Pain Management, CAPLYTA, SHINGRIX, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, GIMOTI, FARXIGA, CAPVAXIVE, Ozempic.
Industry payments across GA — which companies pay providers there.
